Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06184373 · ClinicalTrials.gov registry record
Early Investigation of Glucose Monitoring After Gestational Diabetes Pilot
A clinical trial of Gestational Diabetes and Hyperglycemia, sponsored by Ohio State University.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT06184373: Recruiting study of Gestational Diabetes and Hyperglycemia, sponsored by Ohio State University.
NCT06184373 is a study of Gestational Diabetes and Hyperglycemia that is actively recruiting participants, run by Ohio State University. The registered enrollment target is 20 participants, below the 322-participant average among 41 other Gestational Diabetes trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06184373, a study of Gestational Diabetes and Hyperglycemia, is actively recruiting participants, sponsored by Ohio State University.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
One third of women with gestational diabetes (GDM), diabetes diagnosed during pregnancy, have abnormal glucose levels within 3 years after pregnancy, but follow up is low. Continuous glucose monitors (CGM), a small sensor inserted under the skin, may be able to screen women with GDM for diabetes risk. The investigators will ask postpartum women to use CGM at 6-8 weeks postpartum and answer surveys about quality of life after wearing the CGM. The investigators will collect data on blood glucose trends for future studies if participants find CGM use acceptable. The investigators hope to learn if CGM could improve postpartum follow up experiences for people with recent GDM.
Primary Outcome
As determined by survey
Conditions Studied
Interventions
- DEVICE Continuous glucose monitor
- DIAGNOSTIC_TEST Hemoglobin A1c
- DIAGNOSTIC_TEST Oral Glucose Tolerance Test
Study Locations (1)
Ohio
- Ohio State University Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-06-06 |
| Est. Completion | 2027-05-30 |
What NCT06184373 shows while recruiting
NCT06184373 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 322-participant average among 41 other Gestational Diabetes trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Gestational Diabetes appearing as the primary indexed condition, and to 3 interventions - of which Continuous glucose monitor is the first listed.
NCT06184373 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06184373 about?
NCT06184373 is a clinical study titled "Early Investigation of Glucose Monitoring After Gestational Diabetes Pilot". One third of women with gestational diabetes (GDM), diabetes diagnosed during pregnancy, have abnormal glucose levels within 3 years after pregnancy, but follow up is low. Continuous glucose monitors (CGM), a small sensor inserted under the skin, may be able to screen women with GDM for diabetes ris...
What is the current status of trial NCT06184373?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2025-06-06. Estimated completion is 2027-05-30.
What conditions does trial NCT06184373 study?
This clinical trial studies the following conditions: Gestational Diabetes, Hyperglycemia.
What interventions are being tested in trial NCT06184373?
The interventions under investigation include: Continuous glucose monitor (DEVICE), Hemoglobin A1c (DIAGNOSTIC_TEST), Oral Glucose Tolerance Test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06184373?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06184373 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gestational Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06184373's enrollment target sits among peer trials
20 39th of 41 higher than 2 of 41 other Gestational Diabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gestational Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nutrition Optimization and Community Upliftment for Postpartum Recovery
RECRUITING · NA
-
Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes (START 2)
RECRUITING · NA
-
Delivering HOPE (Helping Women Optimize Prenatal Equity)
RECRUITING · NA
-
iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes
RECRUITING · NA
-
Evaluating the Efficacy of GPT-based Nutrition and Diabetic Counseling in Gestational Diabetes Management: A Randomized Controlled Trial (AIM-GDM)
RECRUITING · NA
-
Growth Hormone Resistance of Beta-cells
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI